This trial has completed recruitment on this platform, and is no longer accepting new referrals.
A study to test the safety and effectiveness of the combination of tucatinib and trastuzumab in people with HER2+ metastatic or unresectable colorectal cancer
Trial ID: NCT03043313
Please visit https://clinicaltrials.gov/study/NCT03043313 for more information.
This trial is no longer recruiting participants. Please visit https://clinicaltrials.gov/study/NCT03043313 for more information.
This trial is no longer recruiting participants. Please visit https://clinicaltrials.gov/study/NCT03043313 for more information.
Please visit https://clinicaltrials.gov/study/NCT03043313 for more information.